Diagnostic Imaging Services Market (Imaging Modality: X-ray, Magnetic Resonance Imaging [MRI], Ultrasound, Computed Tomography [CT], Nuclear Imaging, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Diagnostic Imaging Services Market (Imaging Modality: X-ray, Magnetic Resonance Imaging [MRI], Ultrasound, Computed Tomography [CT], Nuclear Imaging, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Diagnostic Imaging Services Market – Scope of Report

TMR’s report on the global usage-based insurance market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global usage-based insurance market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global usage-based insurance market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the usage-based insurance market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global usage-based insurance market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global usage-based insurance market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global usage-based insurance market.

The report delves into the competitive landscape of the global usage-based insurance market. Key players operating in the global usage-based insurance market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global usage-based insurance market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market usage-based insurance.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Diagnostic Imaging Services Market
4. Market Overview
4.1. Introduction
4.1.1. Imaging Modality Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Diagnostic Imaging Services Market Analysis and Forecast, 2017 - 2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Developments
5.2. Installed Base Scenario
5.3. Reimbursement Scenario Assessment
5.4. Regulatory Scenario Assessment
5.5. Key Disease Prevalence Statistics
5.6. List of Private Diagnostic Centers
5.7. Covid-19 Impact Analysis
6. Global Diagnostic Imaging Services Market Analysis and Forecast, By Imaging Modality
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Imaging Modality, 2017 - 2031
6.3.1. X-ray
6.3.2. Magnetic Resonance Imaging (MRI)
6.3.3. Ultrasound
6.3.4. Computed Tomography (CT)
6.3.5. Nuclear Imaging
6.3.6. Others
6.4. Market Attractiveness By Imaging Modality
7. Global Diagnostic Imaging Services Market Analysis and Forecast, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Application, 2017 - 2031
7.3.1. Cardiology
7.3.2. Gynecology/Obs
7.3.3. Oncology
7.3.4. Orthopedics & Musculoskeletal
7.3.5. Neurology & Spine
7.3.6. General Imaging
7.4. Market Attractiveness By Application
8. Global Diagnostic Imaging Services Market Analysis and Forecast, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2017 - 2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Diagnostic Centers
8.3.4. Others
8.4. Market Attractiveness By End-user
9. Global Diagnostic Imaging Services Market Analysis and Forecast, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Diagnostic Imaging Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Imaging Modality, 2017 - 2031
10.2.1. X-ray
10.2.2. Magnetic Resonance Imaging (MRI)
10.2.3. Ultrasound
10.2.4. Computed Tomography (CT)
10.2.5. Nuclear Imaging
10.2.6. Others
10.3. Market Value Forecast By Application, 2017 - 2031
10.3.1. Cardiology
10.3.2. Gynecology/Obs
10.3.3. Oncology
10.3.4. Orthopedics & Musculoskeletal
10.3.5. Neurology & Spine
10.3.6. General Imaging
10.4. Market Value Forecast By End-user, 2017 - 2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Diagnostic Centers
10.4.4. Others
10.5. Market Value Forecast By Country, 2017 - 2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Imaging Modality
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Diagnostic Imaging Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Imaging Modality, 2017 - 2031
11.2.1. X-ray
11.2.2. Magnetic Resonance Imaging (MRI)
11.2.3. Ultrasound
11.2.4. Computed Tomography (CT)
11.2.5. Nuclear Imaging
11.2.6. Others
11.3. Market Value Forecast By Application, 2017 - 2031
11.3.1. Cardiology
11.3.2. Gynecology/Obs
11.3.3. Oncology
11.3.4. Orthopedics & Musculoskeletal
11.3.5. Neurology & Spine
11.3.6. General Imaging
11.4. Market Value Forecast By End-user, 2017 - 2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Diagnostic Centers
11.4.4. Others
11.5. Market Value Forecast By Country, 2017 - 2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Imaging Modality
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country
12. Asia Pacific Diagnostic Imaging Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Imaging Modality, 2017 - 2031
12.2.1. X-ray
12.2.2. Magnetic Resonance Imaging (MRI)
12.2.3. Ultrasound
12.2.4. Computed Tomography (CT)
12.2.5. Nuclear Imaging
12.2.6. Others
12.3. Market Value Forecast By Application, 2017 - 2031
12.3.1. Cardiology
12.3.2. Gynecology/Obs
12.3.3. Oncology
12.3.4. Orthopedics & Musculoskeletal
12.3.5. Neurology & Spine
12.3.6. General Imaging
12.4. Market Value Forecast By End-user, 2017 - 2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Diagnostic Centers
12.4.4. Others
12.5. Market Value Forecast By Country, 2017 - 2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Imaging Modality
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country
13. Latin America Diagnostic Imaging Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Imaging Modality, 2017 - 2031
13.2.1. X-ray
13.2.2. Magnetic Resonance Imaging (MRI)
13.2.3. Ultrasound
13.2.4. Computed Tomography (CT)
13.2.5. Nuclear Imaging
13.2.6. Others
13.3. Market Value Forecast By Application, 2017 - 2031
13.3.1. Cardiology
13.3.2. Gynecology/Obs
13.3.3. Oncology
13.3.4. Orthopedics & Musculoskeletal
13.3.5. Neurology & Spine
13.3.6. General Imaging
13.4. Market Value Forecast By End-user, 2017 - 2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Diagnostic Centers
13.4.4. Others
13.5. Market Value Forecast By Country, 2017 - 2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Imaging Modality
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country
14. Middle East & Africa Diagnostic Imaging Services Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Imaging Modality, 2017 - 2031
14.2.1. X-ray
14.2.2. Magnetic Resonance Imaging (MRI)
14.2.3. Ultrasound
14.2.4. Computed Tomography (CT)
14.2.5. Nuclear Imaging
14.2.6. Others
14.3. Market Value Forecast By Application, 2017 - 2031
14.3.1. Cardiology
14.3.2. Gynecology/Obs
14.3.3. Oncology
14.3.4. Orthopedics & Musculoskeletal
14.3.5. Neurology & Spine
14.3.6. General Imaging
14.4. Market Value Forecast By End-user, 2017 - 2031
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Diagnostic Centers
14.4.4. Others
14.5. Market Value Forecast By Country, 2017 - 2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Imaging Modality
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2021)
15.3. Company Profiles
15.3.1. RadNet, Inc.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Financial Analysis
15.3.1.3. Growth Strategies
15.3.1.4. SWOT Analysis
15.3.2. Center for Diagnostic Imaging (CDI)
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Financial Analysis
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. MedQuest Associates, Inc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Financial Analysis
15.3.3.3. Growth Strategies
15.3.3.4. SWOT Analysis
15.3.4. Siemens Healthineers
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Financial Analysis
15.3.4.3. Growth Strategies
15.3.4.4. SWOT Analysis
15.3.5. Hitachi, Ltd.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Financial Analysis
15.3.5.3. Growth Strategies
15.3.5.4. SWOT Analysis
15.3.6. Carestream Health
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Financial Analysis
15.3.6.3. Growth Strategies
15.3.6.4. SWOT Analysis
15.3.7. Koninklijke Philips N.V.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Financial Analysis
15.3.7.3. Growth Strategies
15.3.7.4. SWOT Analysis
15.3.8. GE Healthcare
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Financial Analysis
15.3.8.3. Growth Strategies
15.3.8.4. SWOT Analysis
15.3.9. Shimadzu Corporation
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Financial Analysis
15.3.9.3. Growth Strategies
15.3.9.4. SWOT Analysis
15.3.10. Dignity Health (CommonSpirit Health)
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Financial Analysis
15.3.10.3. Growth Strategies
15.3.10.4. SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings